DFTX
Definium Therapeutics, Inc.
+0.94 (+2.48%)38.79USD704K成交股數5.2B市值–本益比(近四季)1117.5股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | 906K | 1.2M | 1.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 48.7M | 41.5M | 33.5M | 31.0M | 29.8M | 23.4M | 17.2M | 14.6M | 11.7M | 11.5M | 13.2M | 14.8M |
| 銷售管理費用 | 26.4M | 17.7M | 14.1M | 14.7M | 11.1M | 8.8M | 7.6M | 9.8M | 10.5M | 10.7M | 8.4M | 14.4M |
| 營業利益 | −75.1M+84% | −59.2M+84% | −47.6M+92% | −45.7M+87% | −40.9M+84% | −32.2M+45% | −24.8M+15% | −24.5M-16% | −22.2M | −22.2M | −21.6M | −29.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | -2,450.8% | -1,858.6% | -2,226.1% |
| 稅後淨利 | −159M+272% | −77.1M+230% | −50.4M+269% | −67.3M+1049% | −42.7M-21% | −23.3M-2% | −13.7M-24% | −5.9M-80% | −54.4M | −23.9M | −17.9M | −29.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | -2,634.0% | -1,541.1% | -2,222.0% |
| 稀釋 EPS | -1.44+188% | -0.71+103% | -0.43+59% | -0.78+200% | -0.50-56% | -0.35-40% | -0.27-40% | -0.26-66% | -1.14 | -0.58 | -0.45 | -0.76 |
| 稀釋股數 | 111M | 109M | 89.3M | 85.9M | 85.3M | 87.1M | 80.2M | 75.3M | 47.9M | 39.2M | 39.7M | 38.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 655M | 263M | 258M | 20.0M | 33.4M | 82.9M | 295M | 243M | 252M | 99.7M | 118M | 117M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.1B | 401M | 440M | 237M | 265M | 275M | 320M | 268M | 276M | 125M | 142M | 142M |
| 有息負債 | 36.5M | 40.8M | 40.6M | 40.4M | 41.2M | 22.0M | 24.3M | 24.3M | 14.2M | 14.1M | 14.1M | – |
| 總負債 | 194M | 122M | 108M | 106M | 79.7M | 52.5M | 57.6M | 66.1M | 79.5M | 46.4M | 45.6M | 36.1M |
| 股東權益 | 919M | 279M | 332M | 131M | 185M | 223M | 262M | 202M | 196M | 78.1M | 96.0M | 106M |
| 負債比 | 17.5% | 30.5% | 24.5% | 44.9% | 30.1% | 19.1% | 18.0% | 24.7% | 28.8% | 37.3% | 32.2% | 25.4% |
| 淨現金(現金 − 有息負債) | 619M | 222M | 217M | −20.4M | −7.8M | 60.8M | 271M | 219M | 238M | 85.6M | 104M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −42.6M+45% | – | – | – | −29.4M | – | – | −16.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −184M | –% | -2.06 | – |
| FY2024 | – | – | −109M | –% | -1.54 | – |
| FY2023 | 4.7M | +212.0% | −95.7M | -2,052.6% | -2.44 | – |
| FY2022 | 1.5M | -516.4% | −56.8M | -3,799.1% | -1.84 | – |
| FY2021 | −359K | +118.9% | −93.0M | 25,915.3% | -3.40 | – |
| FY2020 | −164K | – | −33.9M | 20,693.3% | -0.13 | – |
| FY2019 | – | – | – | –% | – | – |